By: MJ Alonso Lab

Desarrollo de nanoterapias para la prevención y tratamiento de COVID-19 (NANODCOV)
August 25, 2023

Expediente: IN852 2021/16
Título: Desarrollo de nanoterapias para la prevención y tratamiento de COVID-19 (NANODCOV)
Miembros del Consorcio: Smart Vitamins, Universidad de Santiago de Compostela (USC), Fundación Instituto de Investigación Sanitario de Santiago de Compostela (FIDIS)

Read More
María José Alonso’s Lab participates in the NOSEVAC Consortium, a new European collaboration to develop nasal vaccines
June 14, 2023

María José Alonso’s and Noemi Csaba’s research groups at the Center for Research in Molecular Medicine and Chronic Diseases (CiMUS) of the University of Santiago de Compostela (USC) will participate in the NOSEVAC Consortium, a new European collaboration to develop nasal vaccines.

Read More
Check out our new OPEN ACCESS publication: ‘Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors’
March 29, 2023

Shubaash Anthiya, Süleyman Can Öztürk, Hamdullah Yanik, Ece Tavukcuoglu, Adem Şahin, Dhrubajyoti Datta, Klaus Charisse, David Moreira Álvarez, María Isabel Loza, Alfonso Calvo, Einar Sulheim, Simon Loevenich, Geir Klinkenberg, Ruth Schmid, Muthiah Manoharan, Güneş Esendağlı, Maria Jose Alonso, ‘Targeted siRNA lipid nanoparticles for the treatment of KRAS-mutant tumors’, Journal of Controlled Release.

Read More
MJ Alonso’s Lab Mini-Congress 2022
December 31, 2022

The Alonso’s Lab mini-congress is an annual event aimed to motivate and encourage PhD students and Post-Doctoral fellows to present their work in an attractive way, yet not losing the essence of the work.

Read More
MJ Alonso’s Lab wishes you a happy New Year!
December 31, 2022

Happy New Year to everyone! We wish you a fabulous 2023, full of great experiences and achievements in science.

Read More
María José Alonso receives the “Doctora de Alcalá” Award from the University of Alcalá de Henares
December 16, 2022

The Spanish Forum of Innovative Companies – Foro Español de Empresas Innovadoras (FEI) has distinguished María José Alonso in its annual awards in the category of ‘Researcher / Innovator 2022’

Read More
María José Alonso’s Lab participates in the ONCOLIBERIX Consortium for the development of oncological drugs of marine origin
December 2, 2022

This consortium, led by PharmaMar, brings together four leading research groups in nanotechnology and oncology.

Read More
The Spanish Forum of Innovative Companies recognizes María José Alonso as ‘Researcher / Innovator 2022’
November 30, 2022

The Spanish Forum of Innovative Companies – Foro Español de Empresas Innovadoras (FEI) has distinguished María José Alonso in its annual awards in the category of ‘Researcher / Innovator 2022’

Read More
María José Alonso receives the ASEICA-Woman Award
November 18, 2022

Professor Alonso has been recognized for her work in promoting and mentoring cancer researchers’ careers.

Read More
Meet Robert Langer, a pioneer in the development of modern RNA vaccines
November 7, 2022

Prof. María José Alonso interviews Prof. Robert Langer, one of the fathers of nanomedicine. Prof. Langer’s interdisciplinary work has had an extraordinary impact in the design and development of novel nanocarriers for the delivery of small molecule drugs and nucleic acids.

Read More